EODData

MEMBERSHIP REGISTER LOG IN

LSE, 0L35: Sarepta Therapeutics INC

10 Nov 2025
LAST:

17.60

CHANGE:
 0.48		OPEN:
17.65		HIGH:
18.12		ASK:
0.00		VOLUME:
1.7K
CHG(%):
2.80		PREV:
17.12		LOW:
17.47		BID:
0.00		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
10 Nov 2517.6518.1217.4717.601.7K
07 Nov 2517.6217.7716.6017.129.5K
06 Nov 2518.3018.7517.4317.6042.0K
05 Nov 2516.5018.5916.3318.2365.0K
04 Nov 2515.2217.7514.3516.83205.8K
03 Nov 2524.3424.7522.7423.7420.7K
31 Oct 2523.4524.1723.0623.975.6K
30 Oct 2523.3023.4322.7823.195.4K
29 Oct 2524.3924.3923.3023.339.8K
28 Oct 2523.5024.3623.3524.1638.1K

COMPANY PROFILE

Name:Sarepta Therapeutics INC
About:Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat Duchenne muscular dystrophy (Duchenne) in patients with confirmed mutation of the dystrophin gene that is amenable to exon 51 skipping; VYONDYS 53 for the treatment of Duchenne in patients with confirmed mutation of the dystrophin gene that is amenable to exon 53 skipping; AMONDYS 45 for the treatment of Duchenne in patients with confirmed mutation of the dystrophin gene that is amenable to exon 45 skipping; and ELEVIDYS, an adeno-associated virus based gene therapy for the treatment of ambulatory pediatric patients with Duchenne with a confirmed mutation in the Duchenne gene. The company is also developing SRP-9003, a limb-girdle muscular dystrophies gene therapy program. It has collaboration and license agreements with F. Hoffman-La Roche Ltd; Arrowhead Pharmaceuticals, Inc.; University of Western Australia; Catalent Maryland, Inc.; Nationwide Children's Hospital; Dyno Therapeutics; Hansa Biopharma; Duke University; and Genethon. The company was incorporated in 1980 and is headquartered in Cambridge, Massachusetts.
Address:215 First Street, Cambridge, MA, United States, 02142
Website:https://www.sarepta.com

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

FUNDAMENTALS

Trailing P/E:-826.50 
Price to Sales:0.51 
Price to Book:0.98 
Profit Margin:-0.02 
Operating Margin:0.19 
Return on Assets:0.00 
Return on Equity:-0.05 
EPS Ratio:-4.29 
Revenue:2.482B 
EBITDA:40.15M 
Shares:66.82M 
Market Cap:1.176B 

TECHNICAL INDICATORS

MA5:17.480.7%
MA10:20.5816.9%
MA20:21.6322.9%
MA50:20.3215.5%
MA100:19.098.5%
MA200:44.99155.6%
STO9:9.72 
STO14:9.72 
RSI14:31.19 
WPR14:-89.49 
MTM14:-4.80
ROC14:-0.21 
ATR:1.80 
Week High:24.7540.6%
Week Low:14.3522.6%
Month High:24.7540.6%
Month Low:14.35155.6%
Year High:138.41686.4%
Year Low:10.4967.9%
Volatility:30.80